Monday, March 02, 2020 9:43:11 AM
No one can guess what Doug is thinking! If it were me I would wait for the official FDA verdict then evaluate where the hydrocolloid approval could take the buyout price. Remember pharms are taking a hit and some projectons are that pps will plummet for many. UEEC is in perfect position to increase many bottom line profits with our hemostyp hemostasis products!!! HOLD THE LINE OR IF WE DRIFT LOWER BUY BUY BUY!
$10+
$10+
Recent UEEC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 09:11:17 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 08:49:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2026 05:15:10 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/15/2026 10:01:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2025 10:20:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 07:44:29 PM
- Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 09/18/2025 12:35:00 PM
- United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th • GlobeNewswire Inc. • 09/16/2025 08:10:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:41:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 01:53:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2025 08:15:27 PM
